Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: The importance of lung exclusion

Chest

Volumn 120, Issue 6, 2001, Pages 1776-1782

  Cugno, Massimo ^a   Nussberger, Jürg ^b   Biglioli, Paolo ^a   Alamanni, Francesco ^a   Coppola, Raffaella ^a   Agostoni, Angelo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiotensin converting enzyme; Bradykinin metabolism; Coagulation; Complement; Extracorporeal circulation; Fibrinolysis; Hypotension

Indexed keywords

ANTIPLASMIN; BRADYKININ; COMPLEMENT; CYTOKINE; PLASMIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMODYNAMICS; HUMAN; HYPOTENSION; INFLAMMATION; LUNG CIRCULATION; LUNG SHUNTING; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHUNTING;

EID: 0035684295     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.6.1776     Document Type: Article

References (38)

1. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
2. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies
3. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic and pharmacological considerations
4. Release of vasoactive substances during cardiopulmonary bypass
5. Blood-surface interactions during cardiopulmonary bypass
6. Initiation of blood coagulation at artificial surfaces
7. 5a anaphylotoxins
8. Contact activation pathway: Inflammation and coagulation
9. Bioregulation of kinins: Kallikrein, kininogens and kininases
10. Plasma bradykinin in angio-oedema
11. Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans
12. Cardiopulmonary bypass increases plasma bradykinin concentrations
13. An enzyme linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma
14. Rapid direct determination of low and high molecular weight kininogen in human plasma by particle concentration fluorescence immunoassay (PCFIA)
15. Detection of in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies
16. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid
17. Radioimmunoassay for anaphylatoxins: A sensitive method for determining complement activation products in biological fluids
18. Evaluation of measurement of human TNF in plasma by ELISA
19. Hemostatic changes in the pulmonary blood during cardiopulmonary bypass
20. Plasma kininogen in extracorporeal circulation and the influence of a protease inhibitor from bovine lung
21. Liberation of kinins during extracorporeal circulation?
22. Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery
23. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children
24. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
25. Antagonizing and measurement: Approaches to understanding of hemodynamic effects of kinins
26. 2-antiplasmin-inhibitor complexes during cardiopulmonary bypass
27. Generation of plasmin during acute attacks of hereditary angioedema
28. The detection and estimation of bradykinin in the circulating blood
29. Angiotensin II overflow from canine skeletal muscle in vivo: Importance of plasma angiotensin I
30. Assembly of contact-phase factors on the surface of the human neutrophil membrane
31. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass
32. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator
33. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery
34. Activation of coagulation and fibrinolysis during cardiothoracic operations
35. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass
36. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis
37. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation
38. Laboratory markers of coagulation and fibrinolysis